Cite

HARVARD Citation

    Letelier, H. et al. (n.d.). PO-1390 SBRT in all-risk prostate cancer patients, first results from a chilean center with Halcyon linac. Radiotherapy and oncology. pp. S1177-S1178. [Online]. 
  
Back to record